Rosendo Luria-Pérez Selected Research

Bax protein (53-86)

1/2020	Cell-Permeable Bak BH3 Peptide Induces Chemosensitization of Hematologic Malignant Cells.
1/2019	Live Attenuated Salmonella enterica Expressing and Releasing Cell-Permeable Bax BH3 Peptide Through the MisL Autotransporter System Elicits Antitumor Activity in a Murine Xenograft Model of Human B Non-hodgkin's Lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rosendo Luria-Pérez Research Topics

Disease

11	Neoplasms (Cancer) 01/2020 - 05/2011
3	Hematologic Neoplasms (Hematological Malignancy) 01/2020 - 07/2011
2	Dengue (Dengue Fever) 01/2022 - 01/2005
2	Lymphoma (Lymphomas) 10/2021 - 01/2020
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2020 - 01/2019
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2020 - 01/2019
2	Infections 01/2019 - 01/2005
1	Kyasanur Forest Disease 01/2022
1	Japanese Encephalitis 01/2022
1	Tick-Borne Encephalitis (Encephalitis, Tick Borne) 01/2022
1	Yellow Fever 01/2022
1	Leukemia 01/2020
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020
1	Dysbiosis 01/2019
1	Inflammation (Inflammations) 01/2019
1	Prostatic Neoplasms (Prostate Cancer) 11/2016
1	Breast Neoplasms (Breast Cancer) 11/2013
1	Multiple Myeloma 07/2011
1	Burkitt Lymphoma (Burkitt's Lymphoma) 05/2011

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2005
3	Peptides (Polypeptides)IBA 01/2020 - 11/2016
3	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 01/2020 - 11/2016
2	Pharmaceutical PreparationsIBA 01/2020 - 01/2019
2	Bax protein (53-86)IBA 01/2020 - 01/2019
2	Immunoglobulin G (IgG)IBA 01/2019 - 11/2013
2	AntigensIBA 01/2019 - 01/2013
2	CytokinesIBA 01/2019 - 11/2013
2	Recombinant ProteinsIBA 11/2016 - 01/2005
2	Transferrin Receptors (Transferrin Receptor)IBA 11/2016 - 07/2011
2	AntibodiesIBA 05/2011 - 01/2005
1	VaccinesIBA 01/2022
1	Amylases FDA Link 10/2021
1	1,1-diphenyl-2-picrylhydrazylIBA 10/2021
1	Type V Secretion SystemsIBA 01/2019
1	Heparin (Liquaemin)FDA LinkGeneric 01/2019
1	Interleukin-12 (IL 12)IBA 01/2019
1	CateninsIBA 01/2019
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2018
1	Apoptosis Regulatory ProteinsIBA 11/2016
1	Cisplatin (Platino)FDA LinkGeneric 11/2016
1	Oncogene Proteins (Oncogene Protein)IBA 11/2013
1	polycefinIBA 11/2013
1	poly(malic acid)IBA 11/2013
1	Interleukin-2 (IL2)IBA 11/2013
1	Antisense OligonucleotidesIBA 11/2013
1	Heterophile AntigensIBA 01/2013
1	IronIBA 11/2011
1	Rituximab (Mabthera)FDA Link 05/2011
1	5-(6)-carboxyfluorescein diacetate succinimidyl ester (CFSE)IBA 05/2011
1	DNA (Deoxyribonucleic Acid)IBA 01/2005
1	Neutralizing AntibodiesIBA 01/2005

Therapy/Procedure

4	Therapeutics 01/2019 - 07/2011
2	Drug Therapy (Chemotherapy) 01/2019 - 11/2016
2	Immunotherapy 01/2018 - 05/2011
1	Autologous Transplantation 07/2011